Skip to main content
Top
Published in:

26-12-2023 | Respiratory Microbiota | Original Contribution

The anti-hyperuricemic and gut microbiota regulatory effects of a novel purine assimilatory strain, Lactiplantibacillus plantarum X7022

Authors: Yuan Zou, Kum-Song Ro, Chentian Jiang, Deyi Yin, Li Zhao, Daihui Zhang, Lei Du, Jingli Xie

Published in: European Journal of Nutrition | Issue 3/2024

Login to get access

Abstract

Purpose

Probiotics have been reported to effectively alleviate hyperuricemia and regulate the gut microbiota. The aim of this work was to study the in vivo anti-hyperuricemic properties and the mechanism of a novel strain, Lactiplantibacillus plantarum X7022.

Methods

Purine content and mRNA expression of purine assimilation related enzymes were determined by HPLC and qPCR, respectively. Hyperuricemic mice were induced by potassium oxonate and hypoxanthine. Uric acid (UA), blood urea nitrogen, creatinine and renal inflammation were examined by kits. The expression of renal UA transporters was subjected to western blotting. Kidney tissues were sectioned for histological analysis. The fecal short-chain fatty acids (SCFAs) were determined by HPLC, and gut microbiota was investigated using the 16S rDNA metagenomic sequencing.

Results

L. plantarum X7022 possesses a complete purine assimilation pathway and can exhaust xanthine, guanine, and adenine by 82.1%, 33.1%, and 12.6%, respectively. The strain exhibited gastrointestinal viability as 44% at the dose of 109 CFU/mL in mice. After four-week administration of the strain, a significant decrease of 35.5% in the serum UA level in hyperuricemic mice was achieved. The diminished contents of fecal propionate and butyrate were dramatically boosted. The treatment also alleviated renal inflammation and restored renal damage. The above physiological changes may due to the inhibited xanthine oxidase (XO) activity, as well as the expressional regulation of UA transporters (GLUT9, URAT1 and OAT1) to the normal level. Notably, gut microbiota dysbiosis in hyperuricemic mice was improved with the inflammation and hyperuricemia related flora depressed, and SCFAs production related flora promoted.

Conclusion

The strain is a promising probiotic strain for ameliorating hyperuricemia.
Appendix
Available only for authorised users
Literature
7.
go back to reference Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CSJ, Wu JY, Chen YT (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. P Natl Acad Sci USA 102(17):4134–4139. https://doi.org/10.1073/pnas.0502360102CrossRef Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CSJ, Wu JY, Chen YT (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. P Natl Acad Sci USA 102(17):4134–4139. https://​doi.​org/​10.​1073/​pnas.​0502360102CrossRef
20.
go back to reference Wang XY, Sun GQ, Feng T, Zhang J, Huang X, Wang T, Xie ZQ, Chu XK, Yang J, Wang H, Chang SS, Gong YX, Ruan LF, Zhang GQ, Yan SY, Lian W, Du C, Yang DB, Zhang QL, Lin FF, Liu J, Zhang HY, Ge CR, Xiao SF, Ding J, Geng MY (2019) Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res 29(10):787–803. https://doi.org/10.1038/s41422-019-0216-xCrossRefPubMedPubMedCentral Wang XY, Sun GQ, Feng T, Zhang J, Huang X, Wang T, Xie ZQ, Chu XK, Yang J, Wang H, Chang SS, Gong YX, Ruan LF, Zhang GQ, Yan SY, Lian W, Du C, Yang DB, Zhang QL, Lin FF, Liu J, Zhang HY, Ge CR, Xiao SF, Ding J, Geng MY (2019) Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res 29(10):787–803. https://​doi.​org/​10.​1038/​s41422-019-0216-xCrossRefPubMedPubMedCentral
21.
go back to reference Xie DW, Shen YL, Su EZ, Du L, Xie JL, Wei DZ (2023) Anti-hyperuricemic, nephroprotective, and gut microbiota regulative effects of separated hydrolysate of alpha-Lactalbumin on potassium oxonate- and hypoxanthine-induced hyperuricemic mice. Mol Nutr Food Res 67(1):2200162. https://doi.org/10.1002/mnfr.202200162CrossRef Xie DW, Shen YL, Su EZ, Du L, Xie JL, Wei DZ (2023) Anti-hyperuricemic, nephroprotective, and gut microbiota regulative effects of separated hydrolysate of alpha-Lactalbumin on potassium oxonate- and hypoxanthine-induced hyperuricemic mice. Mol Nutr Food Res 67(1):2200162. https://​doi.​org/​10.​1002/​mnfr.​202200162CrossRef
22.
go back to reference Jiang CT, Liu YF, Wang YJ, Su EZ, Du L, Tang YJ, Xie JL, Wei DZ (2022) Hypolipidemic effects of the fermented soymilk with a novel Lactiplantibacillus plantarum strain X7021 on mice via modulating lipid metabolism and gut microbiota. Int J Food Sci Technol 57(7):4555–4565. https://doi.org/10.1111/ijfs.15793CrossRef Jiang CT, Liu YF, Wang YJ, Su EZ, Du L, Tang YJ, Xie JL, Wei DZ (2022) Hypolipidemic effects of the fermented soymilk with a novel Lactiplantibacillus plantarum strain X7021 on mice via modulating lipid metabolism and gut microbiota. Int J Food Sci Technol 57(7):4555–4565. https://​doi.​org/​10.​1111/​ijfs.​15793CrossRef
25.
go back to reference Cao T, Li XY, Mao T, Liu H, Zhao QX, Ding XL, Li CG, Zhang LJ, Tian ZB (2017) Probiotic therapy alleviates hyperuricemia in C57BL/6 mouse model. Biomed Res-India 28(5):2244–2249 Cao T, Li XY, Mao T, Liu H, Zhao QX, Ding XL, Li CG, Zhang LJ, Tian ZB (2017) Probiotic therapy alleviates hyperuricemia in C57BL/6 mouse model. Biomed Res-India 28(5):2244–2249
33.
41.
go back to reference Chu YL, Sun SL, Huang YF, Gao Q, Xie XF, Wang P, Li JX, Liang LF, He XH, Jiang YQ, Wang MJ, Yang JH, Chen XM, Zhou C, Zhao Y, Ding F, Zhang Y, Wu XD, Bai XY, Wu JQ, Wei X, Chen XH, Yue Z, Fang XD, Huang QC, Wang Z, Huang RY (2021) Metagenomic analysis revealed the potential role of gut microbiome in gout. Npj Biofilms Microbi 7(1):66. https://doi.org/10.1038/s41522-021-00235-2CrossRef Chu YL, Sun SL, Huang YF, Gao Q, Xie XF, Wang P, Li JX, Liang LF, He XH, Jiang YQ, Wang MJ, Yang JH, Chen XM, Zhou C, Zhao Y, Ding F, Zhang Y, Wu XD, Bai XY, Wu JQ, Wei X, Chen XH, Yue Z, Fang XD, Huang QC, Wang Z, Huang RY (2021) Metagenomic analysis revealed the potential role of gut microbiome in gout. Npj Biofilms Microbi 7(1):66. https://​doi.​org/​10.​1038/​s41522-021-00235-2CrossRef
44.
go back to reference Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M (2012) Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3(5):449–454CrossRefPubMed Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M (2012) Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3(5):449–454CrossRefPubMed
46.
go back to reference Amatjan M, Li N, He PK, Zhang BH, Mai XY, Jiang QL, Xie HC, Shao XN (2023) A novel approach based on gut microbiota analysis and network pharmacology to explain the mechanisms of action of Cichorium intybus L. formula in the improvement of hyperuricemic nephropathy in rats. Drug Des Dev Ther 17:107–128. https://doi.org/10.2147/Dddt.S389811CrossRef Amatjan M, Li N, He PK, Zhang BH, Mai XY, Jiang QL, Xie HC, Shao XN (2023) A novel approach based on gut microbiota analysis and network pharmacology to explain the mechanisms of action of Cichorium intybus L. formula in the improvement of hyperuricemic nephropathy in rats. Drug Des Dev Ther 17:107–128. https://​doi.​org/​10.​2147/​Dddt.​S389811CrossRef
52.
go back to reference Wanchai K, Yasom S, Tunapong W, Chunchai T, Eaimworawuthikul S, Thiennimitr P, Chaiyasut C, Pongchaidecha A, Chatsudthipong V, Chattipakorn S, Chattipakorn N, Lungkaphin A (2018) Probiotic Lactobacillus paracasei HII01 protects rats against obese-insulin resistance-induced kidney injury and impaired renal organic anion transporter 3 function. Clin Sci 132(14):1545–1563. https://doi.org/10.1042/CS20180148CrossRef Wanchai K, Yasom S, Tunapong W, Chunchai T, Eaimworawuthikul S, Thiennimitr P, Chaiyasut C, Pongchaidecha A, Chatsudthipong V, Chattipakorn S, Chattipakorn N, Lungkaphin A (2018) Probiotic Lactobacillus paracasei HII01 protects rats against obese-insulin resistance-induced kidney injury and impaired renal organic anion transporter 3 function. Clin Sci 132(14):1545–1563. https://​doi.​org/​10.​1042/​CS20180148CrossRef
53.
go back to reference Gupta RS, Chen WJ, Adeolu M, Chai YJ (2013) Molecular signatures for the class Coriobacteriia and its different clades; proposal for division of the class Coriobacteriia into the emended order Coriobacteriales, containing the emended family Coriobacteriaceae and Atopobiaceae fam. nov., and Eggerthellales ord. nov., containing the family Eggerthellaceae fam. nov. Int J Syst Evol Microbiol 63:3379–3397. https://doi.org/10.1099/ijs.0.048371-0CrossRefPubMed Gupta RS, Chen WJ, Adeolu M, Chai YJ (2013) Molecular signatures for the class Coriobacteriia and its different clades; proposal for division of the class Coriobacteriia into the emended order Coriobacteriales, containing the emended family Coriobacteriaceae and Atopobiaceae fam. nov., and Eggerthellales ord. nov., containing the family Eggerthellaceae fam. nov. Int J Syst Evol Microbiol 63:3379–3397. https://​doi.​org/​10.​1099/​ijs.​0.​048371-0CrossRefPubMed
Metadata
Title
The anti-hyperuricemic and gut microbiota regulatory effects of a novel purine assimilatory strain, Lactiplantibacillus plantarum X7022
Authors
Yuan Zou
Kum-Song Ro
Chentian Jiang
Deyi Yin
Li Zhao
Daihui Zhang
Lei Du
Jingli Xie
Publication date
26-12-2023
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 3/2024
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-023-03291-w

Other articles of this Issue 3/2024

European Journal of Nutrition 3/2024 Go to the issue

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more